There is no required waiting period between the two injections when given on the same day
Walking emerges as the most referenced activity, not because GLP-1 users are unambitious, but because it requires no performance threshold, no recovery window, and no gym
They are committed to entering the obesity marketeither with the lead candidate (similar to Lillys Zepbound, it is targeting GLP-1 and GIP hormones) or additional drugs that are in phase 1 and preclinical studies, says Andersen
Ozempic dosing schedule: Weeks 1-4: Starting dose 0.25 mg once weekly Weeks 5-8: 0.5 mg once weekly Weeks 9-12: 1 mg once weekly Weeks 13-16: 2 mg once weekly Wegovy Wegovy is FDA-approved for weight management alongside diet and exercise in people with obesity, or people who have overweight and other weight-related health conditions
In ATTAIN-MAINTAIN, participants were randomized to a 12 mg dose of once-daily, oral orforglipron (or matching placebo) which was increased every 4 weeks until the randomized maintenance dose of 36 mg or MTD (24 mg or 36 mg) was reached